Trulip Pharma

Trulip Pharma is the name we have given to the growth strategy we have developed for the coming decade.

The ongoing changes in the pharmaceuticals industry will represent a challenge, but also provide great opportunities. Trulip Pharma intends to seize these opportunities by being a smart, audacious, knowledge-based and a driving player on the market.

The strategies outlined below include activities that our employees and strategic partners engage in daily basis. The work takes place in an atmosphere in which both individual and joint initiatives are actively encouraged. Simple solutions to complex problems are the cornerstone of Trulip Pharma business philosophy. The strategies listed below serve as guidance in the work of achieving our goals.

1. Increased resources for Sales and Marketing, in order to increase market shares.
2. Support for the existing product portfolio through constant improvements in the supply chain to ensure that strategic key products are always 'best in class'.
3. A broadening of the product offering with added value products, which are less exposed to competition and have higher profit margins.
4. Expanding geographically, primarily through establishment on new markets, but also through strategic acquisitions where justified.
5. Developing and continuing partnership models for the licensing and distribution of Trulip Pharmaceuticals products, and also to act as an agent for third parties with the aim of maximising the benefits obtained from our own marketing organisation.

Trulip Pharma includes four ambitious goals, which form the basis for our strategies for sustainable long-term growth.
1. Increase market shares on all markets on which we currently operate and attain a top 50 position.
2. Increase market presence outside Asia and become a global company.
3. Strengthen value in the product portfolio through a well-balanced selection of licensed products and products developed in-house within the focus areas of niche, complex and strategically important products.
4. Develop and maintain a consolidated, first-class global supply chain.